Wyeth related Press Releases
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease COLLEGEVILLE, Pa., June 11... Read more...
Wyeth's CONBRIZA Approved in the EU for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture WEBWIRE - Tuesday, April 28, 2009 Collegeville, Pa. - Wyeth
... Read more...Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquis.
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition Innovative Approach to Research Supporting Nine Diverse Businesses:
... Read more...Approves New Indication for Wyeth's Tygacil (tigecycline) for the Treatment of Adult Patients with Community-Acquired Pneumonia
Approves New Indication for Wyeth's Tygacil (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia COLLEGEVILLE, Pa., March 24, 2009 /PRNewswire-FirstCall/ --
... Read more...Impax Pharmaceuticals to Co-Promote Wyeth's Pristiq
Impax Pharmaceuticals to Co-Promote Wyeth's Pristiq HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that beginning July 1, 2009, Impax Pharmaceuticals, the
... Read more...Wyeth's 7-valent Vaccine For Pneumococcal Disease Registered In Russia
Wyeth's 7-valent Vaccine For Pneumococcal Disease Registered In Russia Wyeth announced today that its 7-valent pneumococcal conjugate vaccine, Prevenar(TM) (Pneumococcal saccharide conjugated
... Read more...Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case MADISON, N.J., March 4 /PRNewswire-FirstCall/ -- The U.S. Supreme Court's ruling in Wyeth v. Levine is disappointing, not only... Read more...
CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
COLLEGEVILLE, Pa., Feb. 19 /PRNewswire-FirstCall/ -- The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), today adopted a... Read more...
Discussions on a Combination of Crucell N.V. (CRXL) and Wyeth (WYE) Discontinued
Discussions on a Combination of Crucell N.V. and Wyeth Discontinued LEIDEN, NETHERLANDS--(MARKET WIRE)--Jan 26, 2009 -- Dutch biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss
... Read more...Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company Diversification, Flexibility and Scale Position New Company for Success in Dynamic Global Health Care Environment
... Read more...Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
